Farma works with pioneering brands, market leaders, provides exclusive molecules and operates in several markets, such as: OTCs, branded and generic drugs.
With several market highlights, among the OTCs are Vodol®, the VitaSupraz® and Bio-C® family of vitamins, Xantinon®, the market leader in hepatoprotectors, and Hytos® in the antitussive category. Among the branded products, the company operates in several therapeutic classes in the segment and offers a diversified portfolio, with consolidated brands in the market, including Ciclo 21®, the contraceptive most consumed by Brazilian women*, Betaprospan®, Font D®, Tandriflan® and Uniprazol®.
We are present in more than 86 thousand points of sale throughout Brazil.**
*Source - IQVIA October 2023 units
**Source: IQVIA MDTR October 2023
*Source: IQVIA Retail 201 Miconazole Market (Retail PPP)